:max_bytes(133120)/d2j5s05om7evfr.cloudfront.net/pubmed-llm-images/40975501/6b8f2dad9575ed36f607684fe6dcb33d_wm.png)
Proteomic profiling of macrophages: effects of inflammatory activation and anti-inflammatory treatment with IBD therapeutics.
Summary: Inflammatory bowel disease (IBD) causes long-term swelling and damage in the gut. White blood cells called macrophages play a big part in causing this swelling. In this study, scientists took human macrophages and turned them "on" using a bacterial trigger (LPS) to mimic what happens in IBD.
Next, they tested three common IBD drugs—mesalazine, prednisolone, and 6-MP—to see how they changed the proteins inside these cells. They found that the bacterial trigger successfully raised levels of inflammation proteins. Each drug then worked in its own unique way: mesalazine made mild changes, prednisolone strongly blocked the inflammation, and 6-MP changed how the cells use energy and survive. This lab test is a great way to study exactly how IBD drugs work!